Improving insulin sensitivity to modulate TTN stiffness, through targeting neuroregulin-1 or via treatment with metformin, reverses the altered phosphorylation of the N2B and PEVK domains found in diabetes patients, showing its therapeutic potential for diastolic dysfunction [28]. The gene discussed is INS; the disease is diabetes mellitus.